This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Academia Sinica, Other. Active years: 2022-2023.
Company Filing History:
1 out of 726 
1 out of 834,453 Years Active: 2022-2023
Title: Innovations of Hua-De Gao in Liposome Technology
Introduction
Hua-De Gao is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of synthetic polypeptides and their applications in liposome technology. With a total of 2 patents, his work focuses on innovative methods for drug delivery and disease treatment.
Latest Patents
Hua-De Gao's latest patents include groundbreaking inventions related to liposomes. One of his notable patents, titled "Liposomes and uses thereof," discloses novel synthetic polypeptides designed for the preparation of liposomes. The synthetic polypeptide comprises a membrane lytic motif, a masking motif, and a cleavable linker. This linker can be activated by various stimuli, such as light, protease, or phosphatase. Upon exposure to the stimulus, the linker separates the masking motif from the membrane lytic motif, triggering membrane lytic activity that collapses the liposome structure. This innovative mechanism allows for the targeted release of encapsulated agents, providing new methods for diagnosing or treating diseases.
Career Highlights
Throughout his career, Hua-De Gao has worked with esteemed institutions, including Academia Sinica. His research has significantly advanced the understanding and application of liposome technology in medical science. His contributions have paved the way for new therapeutic approaches and enhanced drug delivery systems.
Collaborations
Hua-De Gao has collaborated with notable colleagues, including Hsien-Ming Lee and Jia-Lin Hong. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of synthetic polypeptides and liposome research.
Conclusion
Hua-De Gao's innovative work in liposome technology exemplifies the potential of synthetic polypeptides in medical applications. His patents reflect a commitment to advancing healthcare solutions through scientific research and collaboration.